We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.

Nature cell biology | Nov 3, 2010

The Polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing. This function of EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression. Here, we demonstrate that under physiological conditions, cyclin-dependent kinase 1 (CDK1) and cyclin-dependent kinase 2 (CDK2) phosphorylate EZH2 at Thr 350 in an evolutionarily conserved motif. Phosphorylation of Thr 350 is important for recruitment of EZH2 and maintenance of H3K27me3 levels at EZH2-target loci. Blockage of Thr 350 phosphorylation not only diminishes the global effect of EZH2 on gene silencing, it also mitigates EZH2-mediated cell proliferation and migration. These results demonstrate that CDK-mediated phosphorylation is a key mechanism governing EZH2 function and that there is a link between the cell-cycle machinery and epigenetic gene silencing.

Pubmed ID: 20935635 RIS Download

Mesh terms: CDC2 Protein Kinase | Cyclin-Dependent Kinase 2 | DNA-Binding Proteins | Enhancer of Zeste Homolog 2 Protein | Epigenesis, Genetic | Gene Silencing | HEK293 Cells | Humans | Phosphorylation | Polycomb Repressive Complex 2 | Transcription Factors | Tumor Cells, Cultured

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NIGMS NIH HHS, Id: R01 GM049850
  • Agency: NIGMS NIH HHS, Id: GM49850
  • Agency: NCI NIH HHS, Id: R01 CA134514-02
  • Agency: NCI NIH HHS, Id: CA134514
  • Agency: NCI NIH HHS, Id: CA130908
  • Agency: NCI NIH HHS, Id: R01 CA130908
  • Agency: NCI NIH HHS, Id: R01 CA134514
  • Agency: NCI NIH HHS, Id: R01 CA130908-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.